Protalix BioTherapeutics, Inc. (PLX)

USD 1.71

(-1.72%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 84.43 Million 55.78 Million 73.66 Million 67.93 Million 45.39 Million 61.13 Million
Total Current Assets 69.93 Million 44.88 Million 61.66 Million 55.72 Million 32.47 Million 52.98 Million
Cash And Short Term Investments 44.56 Million 22.18 Million 38.98 Million 38.54 Million 17.79 Million 37.8 Million
Cash and Cash Equivalents 23.63 Million 17.11 Million 38.98 Million 18.26 Million 17.79 Million 37.8 Million
Short Term Investments 20.92 Million 5.06 Million 38.98 Million 20.28 Million - -
Net Receivables 5.27 Million 4.58 Million 3.44 Million 2 Million 4.7 Million 4.72 Million
Inventory 19.04 Million 16.8 Million 17.95 Million 13.08 Million 8.15 Million 8.56 Million
Other Current Assets 1.05 Million 536 Thousand 1.28 Million 2.09 Million 698 Thousand 1.87 Million
Total Non-Current Assets 14.5 Million 10.9 Million 11.99 Million 12.21 Million 12.91 Million 8.14 Million
Net PPE 10.88 Million 9.64 Million 9.92 Million 10.41 Million 10.95 Million 6.39 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments - - - - - -
Tax Assets 3.09 Million - - - - -
Other Non Current Assets 527.99 Thousand 1.26 Million 2.07 Million 1.79 Million 1.96 Million 1.75 Million
Other Assets 1.00 - - - - -
Total Liabilities 50.86 Million 66.42 Million 79.7 Million 94.97 Million 115.71 Million 114.01 Million
Total Current Liabilities 45.53 Million 32.42 Million 33.17 Million 86.47 Million 40.17 Million 25.35 Million
Account Payables 4.32 Million 5.86 Million 6.98 Million 7.22 Million 6.49 Million 5.21 Million
Tax Payables 2.87 Million 530 Thousand - - - -
Short Term Debt 21.66 Million 1.11 Million 1.2 Million 59.93 Million 5.44 Million -
Deferred Revenue 2.87 Million 13.17 Million 8.55 Million 5.39 Million 16.33 Million 9.86 Million
Other Current Liabilities 16.67 Million 12.27 Million 16.43 Million 13.92 Million 11.9 Million 10.27 Million
Total Non Current Liabilities 5.33 Million 33.99 Million 46.52 Million 8.49 Million 75.53 Million 88.65 Million
Long-Term Debt 4.62 Million 32.35 Million 32.26 Million 4.46 Million 55.48 Million 47.96 Million
Deferred Revenue Non Current - - 11.79 Million 1.71 Million 16.98 Million 33.02 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 714 Thousand 1.64 Million 2.47 Million 51 Thousand 509 Thousand 5.29 Million
Other Liabilities - - - - - -
Total Equity 33.56 Million -10.64 Million -6.03 Million -27.03 Million -70.32 Million -52.88 Million
Stock Holders Equity 33.56 Million -10.64 Million -6.03 Million -27.03 Million -70.32 Million -52.88 Million
Common Stock 73 Thousand 54 Thousand 46 Thousand 35 Thousand 15 Thousand 148 Thousand
Retained Earnings -381.54 Million -389.86 Million -374.93 Million -347.35 Million -340.82 Million -322.55 Million
Accumulated other comprehensive income - - - - - -29.11 Million
Common Stock Equity 33.56 Million -10.64 Million -6.03 Million -27.03 Million -70.32 Million -52.88 Million
Capital Lease Obligation 4.62 Million 5.28 Million 5.58 Million 5.88 Million 5.66 Million -
Total Investments 20.92 Million 5.06 Million 38.98 Million 20.28 Million - -
Total Debt 26.28 Million 33.47 Million 33.47 Million 64.4 Million 60.92 Million 47.96 Million
Net Debt 2.64 Million 16.36 Million -5.51 Million 46.13 Million 43.13 Million 10.15 Million

Balance Sheet Charts